Correction: MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition. | PLoS Biol;17(10): e3000529, 2019 Oct. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Correction: MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition.

Walle, Lieselotte Vande; Stowe, Irma B; Sácha, Pavel; Lee, Bettina L; Demon, Dieter; Fossoul, Amelie; Van Hauwermeiren, Filip; Saavedra, Pedro H V; Simon, Petr; Subr, Vladimír; Kostka, Libor; Stivala, Craig E; Pham, Victoria C; Staben, Steven T; Yamazoe, Sayumi; Konvalinka, Jan; Kayagaki, Nobuhiko; Lamkanfi, Mohamed.

PLoS Biol ; 17(10): e3000529, 2019 Oct.

Article in En | MEDLINE | ID: mdl-31618263

ABSTRACT

ABSTRACT

[This corrects the article DOI 10.1371/journal.pbio.3000354.].

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: PLoS Biol Journal subject: BIOLOGIA Year: 2019 Document type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: PLoS Biol Journal subject: BIOLOGIA Year: 2019 Document type: Article